124 related articles for article (PubMed ID: 20214477)
1. Antiretroviral therapy in children with tuberculosis: progress toward defining the issues.
Cotton MF; Rabie H; van Zyl GU
J Infect Dis; 2010 Apr; 201(8):1113-4. PubMed ID: 20214477
[No Abstract] [Full Text] [Related]
2. Immune reconstitution syndrome following initiation of antiretroviral therapy in a patient with HIV infection and multidrug-resistant tuberculosis.
Swaminathan S; Padmapriyadarsini C; Narendran G; Thomas BE; Anand S; Rajyalakshmi A
Indian J Chest Dis Allied Sci; 2005; 47(4):299-304. PubMed ID: 16255403
[TBL] [Abstract][Full Text] [Related]
3. Rifamycin-resistant Mycobacterium tuberculosis in the highly active antiretroviral therapy era: a report of 3 relapses with acquired rifampin resistance following alternate-day rifabutin and boosted protease inhibitor therapy.
Jenny-Avital ER; Joseph K
Clin Infect Dis; 2009 May; 48(10):1471-4. PubMed ID: 19368504
[TBL] [Abstract][Full Text] [Related]
4. A delayed immune reconstitution inflammatory syndrome.
Cailhol J; Pizzocolo C; Brauner M; Bouchaud O; Abgrall S
AIDS; 2007 Jan; 21(1):115-6. PubMed ID: 17148980
[No Abstract] [Full Text] [Related]
5. HIV and tuberculosis--a "cursed duo" in the HAART era.
Londhey VA
J Assoc Physicians India; 2009 Oct; 57():681-2. PubMed ID: 20329423
[No Abstract] [Full Text] [Related]
6. Pharmacokinetic interactions between rifabutin and lopinavir/ritonavir in HIV-infected patients with mycobacterial co-infection.
Khachi H; O'Connell R; Ladenheim D; Orkin C
J Antimicrob Chemother; 2009 Oct; 64(4):871-3. PubMed ID: 19628472
[No Abstract] [Full Text] [Related]
7. Mutations at codons 54 and 82 of HIV protease predict virological response of HIV-infected children on salvage lopinavir/ritonavir therapy.
Luis Jiménez J; Resino S; Martinez-Colom A; Bellón JM; Angeles Muñoz-Fernández M;
J Antimicrob Chemother; 2005 Dec; 56(6):1081-6. PubMed ID: 16195257
[TBL] [Abstract][Full Text] [Related]
8. Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries.
Friedland G; Abdool Karim S; Abdool Karim Q; Lalloo U; Jack C; Gandhi N; El Sadr W
Clin Infect Dis; 2004 Jun; 38 Suppl 5():S421-8. PubMed ID: 15156433
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of HIV-infected children with tuberculosis who are started on antiretroviral therapy in Malawi.
Bong CN; Chen SC; Jong YJ; Tok TS; Hsu CF; Schouten EJ; Makombe SD; Yu JK; Harries AD
Int J Tuberc Lung Dis; 2007 May; 11(5):534-8. PubMed ID: 17439677
[TBL] [Abstract][Full Text] [Related]
10. [Leishmanial parasitation of Kaposi's sarcoma in a HIV patient].
Hinojosa MC; González MI; Martínez G; Ginés A
Rev Esp Quimioter; 2011 Mar; 24(1):54-5. PubMed ID: 21412673
[No Abstract] [Full Text] [Related]
11. The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.
Braitstein P; Nyandiko W; Vreeman R; Wools-Kaloustian K; Sang E; Musick B; Sidle J; Yiannoutsos C; Ayaya S; Carter EJ
Pediatr Infect Dis J; 2009 Jul; 28(7):626-32. PubMed ID: 19451858
[TBL] [Abstract][Full Text] [Related]
12. Plasma nevirapine levels and 24-week efficacy in HIV-infected patients receiving nevirapine-based highly active antiretroviral therapy with or without rifampicin.
Manosuthi W; Sungkanuparph S; Thakkinstian A; Rattanasiri S; Chaovavanich A; Prasithsirikul W; Likanonsakul S; Ruxrungtham K
Clin Infect Dis; 2006 Jul; 43(2):253-5. PubMed ID: 16779754
[TBL] [Abstract][Full Text] [Related]
13. Hypercalcaemia complicating immune reconstitution in an HIV-infected patient with disseminated tuberculosis.
Ferrand RA; Elgalib A; Newsholme W; Childerhouse A; Edwards SG; Miller RF
Int J STD AIDS; 2006 May; 17(5):349-50. PubMed ID: 16643687
[TBL] [Abstract][Full Text] [Related]
14. Laryngeal lymphomatoid granulomatosis in a HIV patient.
Domínguez-Durán E; Luque-Márquez R; Fontillón-Alberdi M; Abrante-Jiménez A
Enferm Infecc Microbiol Clin; 2011; 29(7):552-3. PubMed ID: 21501906
[No Abstract] [Full Text] [Related]
15. HIV infection, pneumonic patch with tuberculosis and hepatitis--a case report.
Das VN; Pandey K; Kumar N; Hassan SM; Bhattacharya SK
J Commun Dis; 2005 Jun; 37(2):155-7. PubMed ID: 16749282
[No Abstract] [Full Text] [Related]
16. The extraordinary hope of antiretroviral therapy in South Africa (even for patients with tuberculosis or kaposi sarcoma!).
Flanigan TP; Campbell T; Harwell J; Kumarasamy N
J Infect Dis; 2005 Feb; 191(3):321-3. PubMed ID: 15633089
[No Abstract] [Full Text] [Related]
17. Diagnostic and management challenges for childhood tuberculosis in the era of HIV.
Marais BJ; Graham SM; Cotton MF; Beyers N
J Infect Dis; 2007 Aug; 196 Suppl 1():S76-85. PubMed ID: 17624829
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing delay in initiating antiretroviral therapy among HIV infected patients coinfected with tuberculosis.
Chilton D; Edwards SG; Pellegrino P; Miller RF
Thorax; 2008 Oct; 63(10):935-6. PubMed ID: 18820121
[No Abstract] [Full Text] [Related]
19. Long-term follow-up of 414 HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir-containing highly active antiretroviral therapy.
Kline MW; Rugina S; Ilie M; Matusa RF; Schweitzer AM; Calles NR; Schwarzwald HL
Pediatrics; 2007 May; 119(5):e1116-20. PubMed ID: 17420261
[TBL] [Abstract][Full Text] [Related]
20. Prevention of invasive pneumococcal disease in HIV-infected children: expanding the toolbox.
Abzug MJ; Pelton SI
J Infect Dis; 2009 Apr; 199(8):1109-11. PubMed ID: 19265480
[No Abstract] [Full Text] [Related]
[Next] [New Search]
